Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
IMPACT IN ACTION: Cure Brain Cancer Foundation Launches Inaugural 5-Year Guardian Trust Early Career Fellowship valued at $575,000
-
LUXH IMPORTANT DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages LuxUrban Hotels, Inc. Investors to Secure Counsel Before Important April 12 Deadline in Securities Class Action – LUXH
-
Patriot Announces Final 2023 Drill Hole Results for the CV13 and CV9 Pegmatites, Corvette, Quebec, Canada
-
Rio Tinto appoints Bold Baatar as Chief Commercial Officer
-
Update on Internal Matters at AnalytixInsight
-
Change to Perseus's Senior Management Team
-
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Associatio
-
Alcon Publishes Agenda for 2024 Annual General Meeting
-
Saturday Lotto Draw no. 4457 and Super 66 Draw no. 4457
-
Union calls for major reform after Melbourne Uni fined $75,000
-
MEDIA ALERT: Public Forum in Adelaide April 20th
-
Monster Energy's Brendan Allen Defeats Chris Curtis at UFC Fight Night 240 in Las Vegas
-
Israeli government must face consequences for blocking humanitarian aid
-
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Asso
-
Meet SHOKI ($SHOKI): BSC Blockchain's Newest Meme Sensation Stirring Up the Pond
-
Meet SHOKI ($SHOKI): BSC Blockchain's Newest Meme Sensation Stirring Up the Pond
-
Web3 Goes Borderless: FuturesAI Launches Next-Gen Derivatives Trading Platform
-
Insights into Crypto Investments: Bitcoin (BTC), Ethereum (ETH), and Furrever Token (FURR) Guide
-
FedUni NTEU members call on Vice Chancellor to resign and will campaign to stop his sweeping job cuts
-
Mitochondrial Disease Costing Australians $1 Billion Each Year
-
Geneos Therapeutics Announces Positive Phase 1/2 Data for GT-30 Trial of Personalized Therapeutic Cancer Vaccine
-
Affini-T Therapeutics Presents Preclinical Data from its Oncogenic Driver Programs Targeting KRAS G12D and p53 R175H at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Edgewood Oncology Announces Positive Efficacy Data From Investigator-Sponsored Study of BTX-A51 in Preclinical Models of Liposarcoma
-
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
-
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL
-
Monthly ministerial diary disclosures among measures proposed to enhance political transparency
-
Adelaide's Largest Mosque Celebrates Eid-ul-Fitr on April 11
-
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
-
THIS WEEKEND: International Cake Show Australia to bring the stars and the sweetness to Brisbane from April 12 to 14
-
World leaders gather in Rwanda to mark the 30th anniversary of the Genocide against the Tutsi
-
Unite for change: IEU launches pay rise campaign for preschools
-
Unaffordable Australia: The Surprising Income You Need to Rent Comfortably
-
AUTODESK (ADSK): Kaplan Fox & Kilsheimer LLP Investigates Autodesk for Potential Securities Law Violations and Encourages Investors to Contact the Firm
-
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with
-
IMMAF and BitDelta Sign Groundbreaking Partnership to Shape Future of Mixed Martial Arts
-
PredxBio Unveils Revolutionary SpaceIQ™ Platform Ushering in a New Era of Spatial Multi-Omics at 2024 AACR Annual Meeting
-
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Canc
-
LED Solutions Rebrands as Avendor, Revolutionizing Pro AV with Real-Time Inventory Data and Flexible Client Solutions
-
Ribometrix Presents First c-MYC Data Validating RNA-Targeting Platform and Demonstrates Synergistic Potential of eIF4E Program at AACR 2024
-
BridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibute-CM Phase 3 Study in Patients with Transthyretin Amyloid Cardi
-
COCM Strengthens Its Team with Key Appointments to Support Enhanced Housing Program and Financial Operations
-
COCM Announces Strategic Leadership Changes and New Executive Appointments
-
Securing Canada's AI advantage
-
HawkEye 360's Clusters 8 & 9 Satellites Ready for Spring Launch with SpaceX
-
Kaplan Fox & Kilsheimer LLP Reminds Shoals Investors (NASDAQ: SHLS) of a Class Action Lawsuit and May 21, 2024 Lead Plaintiff Deadline
-
Casi el 90% de los brasileños admite haber creído noticias falsas
-
La UNESCO reconoce geoparque brasileño dentro de su red mundial
-
Sindicatos e especialistas questionam venda da Avibras a estrangeiros
-
UFF presta homenagem a aluno desaparecido durante a ditadura militar

